Mendes Eduarda, Aljnadi Israa M, Bahls Bárbara, Victor Bruno L, Paulo Alexandra
Faculty of Pharmacy, Research Institute for Medicines (iMed.Ulisboa), Universidade de Lisboa, 1649-003 Lisbon, Portugal.
Faculty of Sciences, BioISI, Biosystems and Integrative Sciences Institute, Universidade de Lisboa, 1749-016 Lisbon, Portugal.
Pharmaceuticals (Basel). 2022 Feb 28;15(3):300. doi: 10.3390/ph15030300.
Organic small molecules that can recognize and bind to G-quadruplex and i-Motif nucleic acids have great potential as selective drugs or as tools in drug target discovery programs, or even in the development of nanodevices for medical diagnosis. Hundreds of quadruplex-interactive small molecules have been reported, and the challenges in their design vary with the intended application. Herein, we survey the major achievements on the therapeutic potential of such quadruplex ligands, their mode of binding, effects upon interaction with quadruplexes, and consider the opportunities and challenges for their exploitation in drug discovery.
能够识别并结合G-四链体和i-基序核酸的有机小分子,作为选择性药物或用于药物靶点发现项目的工具,甚至在用于医学诊断的纳米器件开发中,都具有巨大潜力。已报道了数百种与四链体相互作用的小分子,其设计面临的挑战因预期应用而异。在此,我们综述了此类四链体配体在治疗潜力、结合模式、与四链体相互作用的影响等方面的主要成果,并探讨了在药物发现中开发利用它们的机遇与挑战。